Vilnius, Lithuania & Limassol, Cyprus—March 3, 2026—The German Medical Institute has selected Oxipit as its chest X-ray AI partner following a structured clinical evaluation of three leading vendors across more than 700 real-world cases. The assessment focused on clinical reliability, workflow integration, reporting efficiency and practical usability in daily radiology operations. Oxipit was chosen to support pathology detection (CAD), smart triage, and semi-autonomous pre-populated reports—all integrated directly into the PACS workflow via the Newton’s Tree platform.
The decision followed a rigorous clinical evaluation focused on identifying the AI solution that best supports daily radiology reporting in practice. The radiology team assessed how different systems integrate into existing workflows, how results are presented to clinicians, and how effectively each solution could contribute to efficient and confident reporting in routine clinical use.
“We conducted a thorough evaluation across multiple AI vendors to understand what would work best in our environment,” said Paul Doolan, Director of AI and Senior Medical Physicist at the German Medical Institute. “Oxipit showed consistent performance in identifying normal studies and presented outputs in a way that integrates naturally into our reporting workflow. This combination made the difference. We see clear value in how this can support efficiency while maintaining clinical oversight.”
The Oxipit CXR Suite combines ChestEye CAD for detection of 75 radiological findings, intelligent case prioritisation, and semi-autonomous reporting, built on the same foundation as Oxipit’s flagship innovation—the world’s first CE-certified autonomous healthy chest X-ray reporting solution, which safely removes routine normal studies from the radiologist’s worklist while maintaining full clinical oversight.
“By conducting a structured clinical evaluation and moving forward with routine AI use in chest X-ray reporting, the German Medical Institute is taking a leading role in AI adoption in the region. We are proud that Oxipit was selected as the solution that best supports this step, reflecting our focus on building AI that works naturally inside daily radiology workflows,” said Peter Corscadden, CEO of Oxipit.
About German Medical Institute
The German Medical Institute in Limassol is a leading hospital in Cyprus, providing advanced diagnostic and treatment services with a strong focus on innovation and clinical excellence. With state-of-the-art facilities, highly specialized medical and nursing staff, and cutting-edge technology, the Institute ensures high-quality care based on international standards and a personalized approach for every patient. Its mission is to provide comprehensive healthcare services that combine scientific excellence, safety, and a patient-centered philosophy.
About Oxipit
Founded in 2017 by experts in medicine and data science, Oxipit is a leader in AI-based medical imaging. The company introduced ChestEye in 2019 for detection of 75 chest X-ray findings and launched ChestLink in 2022 as the world’s first CE Class IIb certified solution capable of identifying normal chest X-rays with 99.9% sensitivity. In 2026, Oxipit expanded its portfolio into chest CT and musculoskeletal X-ray imaging, continuing to support radiologists through workflow-integrated detection, prioritisation, and reporting support in daily clinical practice worldwide.